Here are four key points:
1. Even as the interest dropped, the days to cover came in at four.
2. The updated interest stood at 1.3 percent of the stocks floats.
3. The 52-week high of the share price is $45.84 and the 52-week low is $29.91.
4. With approximately 41.5 million shares in circulation, the company has a market cap of $1.79 billion.
More articles on GI/endoscopy:
CCFA, AGA & Janssen Biotech create new grant program for epigenetic research in IBD
Dr. Nolan Perez named Texas Lyceum director
GI/endoscopy company stock report – Feb.13, 2015
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
